195 related articles for article (PubMed ID: 30664152)
1. miR‑122 and miR‑199 synergistically promote autophagy in oral lichen planus by targeting the Akt/mTOR pathway.
Wang L; Wu W; Chen J; Li Y; Xu M; Cai Y
Int J Mol Med; 2019 Mar; 43(3):1373-1381. PubMed ID: 30664152
[TBL] [Abstract][Full Text] [Related]
2. Activated Akt/mTOR-autophagy in local T cells of oral lichen planus.
Zhang N; Zhang J; Tan YQ; Du GF; Lu R; Zhou G
Int Immunopharmacol; 2017 Jul; 48():84-90. PubMed ID: 28482233
[TBL] [Abstract][Full Text] [Related]
3. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
Wang F; Zhang J; Zhou G
Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
[TBL] [Abstract][Full Text] [Related]
4. miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3K/Akt/mTOR pathway.
Wang J; Luo H; Xiao Y; Wang L
Biomed Pharmacother; 2016 May; 80():373-380. PubMed ID: 27133077
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Microarray-Based Identification of Involvement of miR-155 and miR-19a in Development of Oral Lichen Planus (OLP) by Modulating Th1/Th2 Balance via Targeting eNOS and Toll-Like Receptor 2 (TLR2).
Wang L; Wu W; Chen J; Li Y; Xu M; Cai Y
Med Sci Monit; 2018 May; 24():3591-3603. PubMed ID: 29813046
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 1 exhibits the pro-autophagic and anti-apoptotic activity on T cells of oral lichen planus.
Wang F; Tan YQ; Zhang J; Zhou G
Int J Biol Macromol; 2019 Jul; 133():640-646. PubMed ID: 31026523
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
10. Reduced miRNA‑214 expression in oral mucosa contributes to the pathogenesis of oral lichen planus by targeting CD44.
Zheng H; Li S
Mol Med Rep; 2018 Jan; 17(1):1919-1925. PubMed ID: 29138813
[TBL] [Abstract][Full Text] [Related]
11. Aberrant IGF1-PI3K/AKT/MTOR signaling pathway regulates the local immunity of oral lichen planus.
Ma RJ; Tan YQ; Zhou G
Immunobiology; 2019 May; 224(3):455-461. PubMed ID: 30773287
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: a preliminary study.
Shen Z; Du G; Zhou Z; Liu W; Shi L; Xu H
J Oral Pathol Med; 2016 Aug; 45(7):523-7. PubMed ID: 26711064
[TBL] [Abstract][Full Text] [Related]
13. MALT1 Protease Regulates T-Cell Immunity via the mTOR Pathway in Oral Lichen Planus.
Wang XF; Wang F; Zhou G
Inflammation; 2024 Jun; 47(3):939-957. PubMed ID: 38159177
[TBL] [Abstract][Full Text] [Related]
14. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway.
Yang Y; Ma S; Ye Z; Zhou X
J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of miRNA-138 and cyclin D1 in oral lichen planus.
Ghallab NA; Kasem RF; El-Ghani SFA; Shaker OG
Clin Oral Investig; 2017 Nov; 21(8):2481-2491. PubMed ID: 28275859
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of microtubule associated protein 1 light chain 3B, p62 and Beclin1 in lesion tissues of oral lichen planus patients].
Shen MX; Hu WY; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Dec; 57(12):1217-1224. PubMed ID: 36509521
[No Abstract] [Full Text] [Related]
18. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.
Gholizadeh N; Emami Razavi A; Mohammadpour H; Tavakol F; Sheykhbahaei N
Mol Biol Rep; 2020 Feb; 47(2):1223-1232. PubMed ID: 31828562
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
[TBL] [Abstract][Full Text] [Related]
20. Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus.
Zhang WY; Liu W; Zhou YM; Shen XM; Wang YF; Tang GY
Oral Dis; 2012 Apr; 18(3):265-70. PubMed ID: 22077423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
